Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan/hydrochlorothiazide versus losartan in diabetic patients with hypertension
ACTRN12610001024033Phase 4Recruiting
- Sponsor
- Keio University
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of losartan and hydrochlorothiazide in hypertension (HTN) and diabetes mellitus (DM) (2 arms), sponsored by Keio University. Primary endpoint: Vascular and hemodynamic assessment schedule. Started Jan 2007; status: recruiting.
02
Drugs
losartanhydrochlorothiazide
03
Conditions
hypertension (HTN)diabetes mellitus (DM)
Beyond the preview
Go deeper on ACTRN12610001024033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001024033.